Accelerated hepatocellular carcinoma recurrence rate after postoperative direct-acting antivirals treatment – preliminary report

AIM OF THE STUDY: New interferon-free direct-acting antiviral (DAA) therapy has led to major progress in hepatitis C virus (HCV) treatment. Current outcomes are promising, especially in compensated cirrhosis. However, there are reports of accelerated hepatocellular carcinoma (HCC) recurrence after s...

Descripción completa

Detalles Bibliográficos
Autores principales: Warzyszyńska, Karola, Jonas, Maurycy, Wasiak, Dariusz, Kosieradzki, Maciej, Małkowski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731431/
https://www.ncbi.nlm.nih.gov/pubmed/29255807
http://dx.doi.org/10.5114/ceh.2017.71483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731431/
https://www.ncbi.nlm.nih.gov/pubmed/29255807
http://dx.doi.org/10.5114/ceh.2017.71483

Ejemplares similares